CC-1088 Therapy for Chronic Lymphocytic Leukemia: A Phase I/II Trial.
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2010
At a glance
- Drugs CC 1088 (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2010 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
- 27 Sep 2005 New trial record.